Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

A second endogenous cannabinoid that modulates long-term potentiation

Open access
Stella, Nephi, Schweitzer, Paul, Piomelli, Daniele · 1997 · Nature

Abstract

Cannabinoid receptors are molecular targets for marijuana and hashish, the widespread drugs of abuse. These receptors are expressed in areas of the central nervous system that contribute in important ways to the control of memory, cognition, movement and pain perception. Indeed, such functions can be strongly influenced by cannabinoid drugs, with consequences that include euphoria, analgesia, sedation and memory impairment. Although the pharmacology of cannabinoid drugs is now beginning to be understood, we still lack essential information on the endogenous signalling system(s) by which cannabinoid receptors are normally engaged. An endogenous ligand for cannabinoid receptors, anandamide, has been described. Here we report that sn-2 arachidonylglycerol (2-AG), a cannabinoid ligand isolated from intestinal tissue, is present in brain in amounts 170 times greater than anandamide. 2-AG is produced in hippocampal slices by stimulation of the Schaffer collaterals, an excitatory fibre tract that projects from CA3 to CA1 neurons. Formation of 2-AG is calcium dependent and is mediated by the enzymes phospholipase C and diacylglycerol lipase. 2-AG activates neuronal cannabinoid receptors as a full agonist, and prevents the induction of long-term potentiation at CA3-CA1 synapses. Our results indicate that 2-AG is a second endogenous cannabinoid ligand in the central nervous system.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/42015

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 1,496

Metadata

Authors
Stella, N., Schweitzer, P., & Piomelli, D.
Affiliations
  • Neurosciences Institute (US)
  • Scripps Research Institute (US)
Corresponding author
Piomelli, Daniele
Venue
Nature
Published
1997-08-21
Volume
388
Issue
6644
Pages
773-778
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W1591647183
Cited by
1,496
References
31
Citations by year
2026: 16 · 2025: 23 · 2024: 34 · 2023: 38 · 2022: 41 · 2021: 59 · 2020: 44 · 2019: 36 · 2018: 36 · 2017: 41 · 2016: 41 · 2015: 56 · 2014: 51 · 2013: 35 · 2012: 64
FWCI
47.70
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • Howard Hughes Medical Institute
  • McKnight Foundation
  • National Alliance for Research on Schizophrenia and Depression
  • National Institutes of Health
  • National Institute of General Medical Sciences
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
2-arachidonoylglycerol, endocannabinoid system, cannabinoid receptors, long-term potentiation, hippocampus, Schaffer collaterals, CA3-CA1 synapses, anandamide, phospholipase C, diacylglycerol lipase
MeSH terms
Animals, Arachidonic Acids, Astrocytes, Brain, Brain Chemistry, Calcium, Cannabinoids, Cells, Cultured, Diglycerides, Electric Stimulation, Glycerides, Hippocampus, Ligands, Gas Chromatography-Mass Spectrometry, Neurons, Receptors, Drug, Long-Term Potentiation, Receptors, Cannabinoid, Rats, Polyunsaturated Alkamides, Endocannabinoids, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A second endogenous cannabinoid that modulates long-term potentiation. https://app.cochat.ai/papers/10.1038/42015
The paper
Stella, N., Schweitzer, P., & Piomelli, D. (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature. https://doi.org/10.1038/42015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.